Li Tao, MD, PhD

Director
Gilead Sciences

Li Tao, MD, MS, PhD, is a Director of Real-World Evidence at Gilead Sciences. Prior to joining Gilead, Dr. Tao was an epidemiologist focused on research of cancer surveillance and health disparity. At Gilead, she directed real-world studies on HIV prevention and respond to epidemiological requests. Dr. Tao’s research interest is to evaluate real-world PrEP efficacy, safety, adherence, persistence, and utilization patterns.

Poster(s):

• (1556) Increase in New HIV Diagnoses Following Decrease in Use of Pre-Exposure Prophylaxis (PrEP) During the COVID-19 Pandemic
  Friday, October 13, 2023

  12:15 PM – 1:30 PM US ET

• (1557) The Real-World Impact of Pre-Exposure Prophylaxis (PrEP) Prescription Uptake and Dispensing Status on HIV Infection Risk in the US
  Friday, October 13, 2023

  12:15 PM – 1:30 PM US ET